Nama Insights

VanEck Pharmaceutical ETF (PPH)

Health · VanEck · NASDAQ

HealthETF
VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund in the Health category. It has $1.02B in assets, an expense ratio of 0.36% and a 1.99% dividend yield. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Assets under management$1.02B
Expense ratio0.36%
CategoryHealth
Dividend yield1.99%
NAV$119.32
Fund familyVanEck
ExchangeNASDAQ

Top holdings

The largest positions VanEck Pharmaceutical ETF reports, by weight.

HoldingNameWeight
LLY Eli Lilly and Co 20.91%
MRK Merck & Co Inc 13.51%
NVO Novo Nordisk AS ADR 5.59%
PFE Pfizer Inc 5.13%
BMY Bristol-Myers Squibb Co 4.84%
TEVA.TA Teva Pharmaceutical Industries Ltd 4.72%
GSK GSK PLC ADR 4.53%
MCK McKesson Corp 4.33%
COR Cencora Inc 4.25%
HLN Haleon PLC ADR 3.67%

Other Health ETFs

Explore live PPH data on Nama Insights →